PubMed Nucleotide Protein Genome Structure PopSet Taxonomy OMIM

OMIM Update List for October, 2006

Please send your questions to the NCBI Help Desk.

October 31, 2006

New Entries:

610537 DIPEPTIDYL PEPTIDASE VII; DPP7
610538 UBIQUITIN-CONJUGATING ENZYME E2T; UBE2T
Clinical Synopsis for 610127 CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10

Changed Entries:

134370 COMPLEMENT FACTOR H; CFH
134371 COMPLEMENT FACTOR H-RELATED 1; CFHR1
138470 COMPLEMENT FACTOR B; CFB
139250 GROWTH HORMONE 1; GH1
172270 PHOSPHOGLYCERATE KINASE 2; PGK2
601118 CALCIUM-MODULATING CYCLOPHILIN LIGAND; CAMLG
602630 TRANSFORMING GROWTH FACTOR-BETA-INDUCED FACTOR; TGIF
602869 HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN U; HNRPU
604591 PHOSPHATIDYLETHANOLAMINE-BINDING PROTEIN; PBP
605336 COMPLEMENT FACTOR H-RELATED 3; CFHR3
605554 CD244 ANTIGEN; CD244
608603 GLIOMEDIN; GLDN
609412 EXCISION-REPAIR CROSS-COMPLEMENTING, GROUP 8; ERCC8
609413 EXCISION-REPAIR CROSS-COMPLEMENTING, COMPLEMENTATION GROUP 6; ERCC6
610362 RETINA AND ANTERIOR NEURAL FOLD HOMEOBOX-LIKE 1; RAXL1
610538 UBIQUITIN-CONJUGATING ENZYME E2T; UBE2T
Clinical Synopsis for 210600 SECKEL SYNDROME 1
Clinical Synopsis for 606693 KUFOR-RAKEB SYNDROME; KRS
Clinical Synopsis for 606858 PREMATURE CHROMOSOME CONDENSATION WITH MICROCEPHALY AND MENTAL RETARDATION
Clinical Synopsis for 607271 CASPASE 8 DEFICIENCY
Clinical Synopsis for 607330 LATHOSTEROLOSIS
Clinical Synopsis for 610127 CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10

October 30, 2006

New Entries:

610534 DECAPPING ENZYME, SCAVENGER; DCPS
610535 GLAUCOMA 1, OPEN ANGLE, M; GLC1M
610536 GROWTH AND MENTAL RETARDATION, MANDIBULOFACIAL DYSOSTOSIS, MICROCEPHALY,
Clinical Synopsis for 610535 GLAUCOMA 1, OPEN ANGLE, M; GLC1M

Changed Entries:

114290 CAMPOMELIC DYSPLASIA
125240 CD55 ANTIGEN; CD55
137750 GLAUCOMA 1, OPEN ANGLE, A; GLC1A
137760 GLAUCOMA, PRIMARY OPEN ANGLE; POAG
139139 NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 1; NR4A1
154550 MANNOSEPHOSPHATE ISOMERASE; MPI
155145 CLEFT, MEDIAN, OF UPPER LIP WITH POLYPS OF FACIAL SKIN AND NASAL MUCOSA
191170 TUMOR PROTEIN p53; TP53
229600 FRUCTOSE INTOLERANCE, HEREDITARY
248611 BRANCHED-CHAIN KETO ACID DEHYDROGENASE E1, BETA POLYPEPTIDE; BCKDHB
249600 MENTAL RETARDATION SYNDROME, MIETENS-WEBER TYPE
600542 NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 3; NR4A3
600726 INDIAN HEDGEHOG; IHH
601828 NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 2; NR4A2
601844 PROTEIN KINASE, LYSINE-DEFICIENT 4; WNK4
602429 GLAUCOMA 1, OPEN ANGLE, D; GLC1D
602579 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ib
602919 DOCKING PROTEIN 1; DOK1
603383 GLAUCOMA 1, OPEN ANGLE, F; GLC1F
603969 TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 13B; TNFSF13B
604997 DOCKING PROTEIN 2; DOK2
606073 NADPH-DEPENDENT DIFLAVIN OXIDOREDUCTASE 1; NDOR1
606324 PARKINSON DISEASE 7, AUTOSOMAL RECESSIVE EARLY-ONSET; PARK7
606689 GLAUCOMA 1, OPEN ANGLE, B; GLC1B
606693 KUFOR-RAKEB SYNDROME; KRS
607463 PROTEIN PHOSPHATASE 1, REGULATORY SUBUNIT 13-LIKE; PPP1R13L
608160 SRY-BOX 9; SOX9
608695 GLAUCOMA 1, OPEN ANGLE, J; GLC1J
608696 GLAUCOMA 1, OPEN ANGLE, K; GLC1K
609309 MutS, E. COLI, HOMOLOG OF, 2; MSH2
609460 GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME
609669 WD REPEAT-CONTAINING PROTEIN 36; WDR36
609745 GLAUCOMA 1, OPEN ANGLE, I; GLC1I
609887 GLAUCOMA 1, OPEN ANGLE, G; GLC1G
610513 ATPase, TYPE 13A2; ATP13A2
610535 GLAUCOMA 1, OPEN ANGLE, M; GLC1M
Clinical Synopsis for 229300 FRIEDREICH ATAXIA 1; FRDA

October 28, 2006

Changed Entries:

Clinical Synopsis for 608088 NEUROPATHY, HEREDITARY SENSORY, TYPE I, WITH COUGH AND GASTROESOPHAGEAL

October 27, 2006

New Entries:

300620 V-SET AND IMMUNOGLOBULIN DOMAINS-CONTAINING PROTEIN 1; VSIG1
610530 TRIPARTITE MOTIF-CONTAINING 41; TRIM41
610531 FAMILY WITH SEQUENCE SIMILARITY 126, MEMBER A; FAM126A
610532 HYPOMYELINATION AND CONGENITAL CATARACT
610533 WW, C2, AND COILED-COIL DOMAIN-CONTAINING 1; WWC1
Clinical Synopsis for 300602 CLARK-BARAITSER SYNDROME
Clinical Synopsis for 608088 NEUROPATHY, HEREDITARY SENSORY, TYPE I, WITH COUGH AND GASTROESOPHAGEAL
Clinical Synopsis for 610154 DEAFNESS, AUTOSOMAL RECESSIVE 44; DFNB44
Clinical Synopsis for 610156 MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS

Changed Entries:

139210 GROWTH-MENTAL DEFICIENCY SYNDROME OF MYHRE
147681 INTERLEUKIN 11; IL11
147683 INTERLEUKIN 13; IL13
147920 KABUKI SYNDROME
150340 LAMIN B1; LMNB1
152700 SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
153432 LYMPHOCYTE-SPECIFIC PROTEIN; LSP1
153480 BANNAYAN-RILEY-RUVALCABA SYNDROME; BRRS
169500 LEUKODYSTROPHY, ADULT-ONSET, AUTOSOMAL DOMINANT
216100 CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY
217980 CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE
248340 MALPUECH FACIAL CLEFTING SYNDROME
256690 NEUROFACIODIGITORENAL SYNDROME
265430 PULMONARY HYPOPLASIA, PRIMARY
273750 THREE M SYNDROME
300353 V-SET AND IMMUNOGLOBULIN DOMAINS-CONTAINING PROTEIN 4; VSIG4
600129 PHOSPHODIESTERASE 4D, cAMP-SPECIFIC; PDE4D
600555 SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 1; STAT1
600939 INTERLEUKIN 11 RECEPTOR, ALPHA; IL11RA
601373 CHEMOKINE, CC MOTIF, RECEPTOR 5; CCR5
601728 PHOSPHATASE AND TENSIN HOMOLOG; PTEN
603352 BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 5; BIRC5
604147 PITUITARY TUMOR-TRANSFORMING GENE 1; PTTG1
604672 CD209 ANTIGEN; CD209
605397 CD226 ANTIGEN; CD226
605516 CADHERIN 23; CDH23
606011 V-SET AND IMMUNOGLOBULIN DOMAINS-CONTAINING PROTEIN 2; VSIG2
606120 HUMANIN
607562 INTERLEUKIN 23 RECEPTOR; IL23R
607948 MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO INFECTION BY
610532 HYPOMYELINATION AND CONGENITAL CATARACT
Clinical Synopsis for 133020 ERYTHERMALGIA, PRIMARY
Clinical Synopsis for 166300 OSTEOLYSIS, HEREDITARY, OF CARPAL BONES WITH NEPHROPATHY
Clinical Synopsis for 255800 SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1
Clinical Synopsis for 256840 NEUROPATHY, HEREDITARY SENSORY, WITH SPASTIC PARAPLEGIA, AUTOSOMAL
Clinical Synopsis for 277900 WILSON DISEASE
Clinical Synopsis for 300143 MENTAL RETARDATION, X-LINKED 21; MRX21
Clinical Synopsis for 300486 MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE
Clinical Synopsis for 601808 CHROMOSOME 18q DELETION SYNDROME
Clinical Synopsis for 607855 MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A
Clinical Synopsis for 610185 CEREBELLAR HYPOPLASIA, MENTAL RETARDATION, AND QUADRUPEDAL LOCOMOTION

October 26, 2006

New Entries:

610523 TESTIS-SPECIFIC PROTEIN 14; TSGA14
610524 HUMAN ENDOGENOUS RETROVIRUS FRD ENVELOPE PROTEIN
610525 5-PRIME-@NUCLEOTIDASE, CYTOSOLIC, IA; NT5C1A
610526 5-PRIME-@NUCLEOTIDASE, CYTOSOLIC, IB; NT5C1B
610527 THIOREDOXIN DOMAIN-CONTAINING 1; TXNDC1
610529 TUMOR SUPPRESSOR CANDIDATE 1; TUSC1
Clinical Synopsis for 300143 MENTAL RETARDATION, X-LINKED 21; MRX21
Clinical Synopsis for 300486 MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE
Clinical Synopsis for 300578 CHROMOSOME Xp11.3 DELETION SYNDROME
Clinical Synopsis for 609940 MYOPATHY, LIMB-GIRDLE, WITH BONE FRAGILITY
Clinical Synopsis for 610003 CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT
Clinical Synopsis for 610006 2-@METHYLBUTYRYL-CoA DEHYDROGENASE DEFICIENCY
Clinical Synopsis for 610143 DEAFNESS, AUTOSOMAL RECESSIVE 62; DFNB62
Clinical Synopsis for 610153 DEAFNESS, AUTOSOMAL RECESSIVE 49; DFNB49
Clinical Synopsis for 610185 CEREBELLAR HYPOPLASIA, MENTAL RETARDATION, AND QUADRUPEDAL LOCOMOTION

Changed Entries:

107269 CD44 ANTIGEN; CD44
110100 BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS; BPES
126800 DUANE RETRACTION SYNDROME 1; DURS1
142994 HOMEOBOX GENE HB9; HLXB9
145420 HYPERTELORISM, TEEBI TYPE
176263 POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, MEMBER
176450 CURRARINO SYNDROME
184429 SRY-BOX 2; SOX2
191440 ULNAR HYPOPLASIA
206900 MICROPHTHALMIA, SYNDROMIC 3; MCOPS3
219000 FRASER SYNDROME
222600 DIASTROPHIC DYSPLASIA
256050 ATELOSTEOGENESIS, TYPE II; AOII
277900 WILSON DISEASE
310500 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1A; CSNB1A
601835 CHEMOKINE, CC MOTIF, RECEPTOR 6; CCR6
602165 TRIPARTITE MOTIF-CONTAINING PROTEIN 27; TRIM27
602218 SAL-LIKE 1; SALL1
604659 ENDOGENOUS RETROVIRAL FAMILY W, ENV-C7, MEMBER 1; ERVWE1
604962 T-CELL RECEPTOR-ASSOCIATED TRANSMEMBRANE ADAPTOR 1; TRAT1
605493 TRIPARTITE MOTIF-CONTAINING 3; TRIM3
605597 FORKHEAD TRANSCRIPTION FACTOR FOXL2; FOXL2
605684 TRIPARTITE MOTIF-CONTAINING PROTEIN 34; TRIM34
605988 DNA CROSS-LINK REPAIR PROTEIN 1C; DCLRE1C
606718 SOLUTE CARRIER FAMILY 26 (SULFATE TRANSPORTER), MEMBER 2; SLC26A2
606882 ATPase, Cu(2+)-TRANSPORTING, BETA POLYPEPTIDE; ATP7B
607238 COPPER METABOLISM MURR1 DOMAIN-CONTAINING PROTEIN 1; COMMD1
607830 FRAS1 GENE; FRAS1
608945 FRAS1-RELATED EXTRACELLULAR MATRIX PROTEIN 2; FREM2
610517 CONTACTIN-ASSOCIATED PROTEIN-LIKE 3; CNTNAP3
610523 TESTIS-SPECIFIC PROTEIN 14; TSGA14
610527 THIOREDOXIN DOMAIN-CONTAINING 1; TXNDC1
610529 TUMOR SUPPRESSOR CANDIDATE 1; TUSC1
Clinical Synopsis for 105830 ANGELMAN SYNDROME; AS
Clinical Synopsis for 134610 FAMILIAL MEDITERRANEAN FEVER, AUTOSOMAL DOMINANT
Clinical Synopsis for 149730 LACRIMOAURICULODENTODIGITAL SYNDROME; LADD
Clinical Synopsis for 190300 TREMOR, HEREDITARY ESSENTIAL, 1; ETM1
Clinical Synopsis for 227280 FACIOCARDIORENAL SYNDROME
Clinical Synopsis for 245150 KEUTEL SYNDROME
Clinical Synopsis for 249100 FAMILIAL MEDITERRANEAN FEVER; FMF
Clinical Synopsis for 249600 MENTAL RETARDATION SYNDROME, MIETENS-WEBER TYPE
Clinical Synopsis for 250230 METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE
Clinical Synopsis for 250400 METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE
Clinical Synopsis for 300534 MENTAL RETARDATION, X-LINKED, SYNDROMIC, JARID1C-RELATED
Clinical Synopsis for 600143 CEROID LIPOFUSCINOSIS, NEURONAL, 8; CLN8
Clinical Synopsis for 602471 SHORT STATURE, AUDITORY CANAL ATRESIA, MANDIBULAR HYPOPLASIA, SKELETAL
Clinical Synopsis for 606854 POLYMICROGYRIA, BILATERAL FRONTOPARIETAL

October 25, 2006

New Entries:

300618 PHD FINGER PROTEIN 16; PHF16
300619 CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION
610514 PHD FINGER PROTEIN 17; PHF17
610515 PHD FINGER PROTEIN 15; PHF15
610516 GLYCERATE KINASE; GLYCTK
610517 CONTACTN-ASSOCIATED PROTEIN-LIKE 3; CNTNAP3
610518 CONTACTIN-ASSOCIATED PROTEIN-LIKE 4; CNTNAP4
610519 CONTACTIN-ASSOCIATED PROTEIN-LIKE 5; CNTNAP5
610520 CD300 ANTIGEN-LIKE FAMILY, MEMBER G; CD300LG
610521 POTASSIUM CHANNEL TETRAMERIZATION DOMAIN-CONTAINING PROTEIN 12; KCTD12
610522 COORDINATED EXPRESSION TO IRXA2
Clinical Synopsis for 300580 MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION 2, X-LINKED; CFTD2
Clinical Synopsis for 602471 SHORT STATURE, AUDITORY CANAL ATRESIA, MANDIBULAR HYPOPLASIA, SKELETAL
Clinical Synopsis for 608622 HYPERTENSION, DIASTOLIC, RESISTANCE TO

Changed Entries:

108720 ATELOSTEOGENESIS, TYPE I; AOI
112500 BRACHYDACTYLY, TYPE A1; BDA1
116897 CCAAT/ENHANCER-BINDING PROTEIN, ALPHA; CEBPA
118504 CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 4; CHRNA4
118507 CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, BETA POLYPEPTIDE 2; CHRNB2
121011 GAP JUNCTION PROTEIN, BETA-2; GJB2
122700 COUMARIN RESISTANCE
122720 CYTOCHROME P450, SUBFAMILY IIA, POLYPEPTIDE 6; CYP2A6
126455 SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, DOPAMINE),
130720 LATERAL MENINGOCELE SYNDROME
133020 ERYTHERMALGIA, PRIMARY
137750 GLAUCOMA 1, OPEN ANGLE, A; GLC1A
137760 GLAUCOMA, PRIMARY OPEN ANGLE, ADULT-ONSET; POAG
142983 MUSCLE SEGMENT HOMEOBOX, DROSOPHILA, HOMOLOG OF, 1; MSX1
147545 INSULIN RECEPTOR SUBSTRATE 1; IRS1
153245 LYMPHOID ENHANCER-BINDING FACTOR 1; LEF1
157660 MITOCHONDRIAL RNA-PROCESSING ENDORIBONUCLEASE, RNA COMPONENT OF; RMRP
161650 NEBULIN; NEB
164761 REARRANGED DURING TRANSFECTION PROTOONCOGENE; RET
168468 PARATHYROID HORMONE RECEPTOR 1; PTHR1
176260 POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, MEMBER
176876 PROTEIN-TYROSINE PHOSPHATASE, NONRECEPTOR-TYPE, 11; PTPN11
180660 POLYMERASE II, RNA, SUBUNIT A; POLR2A
182452 SOMATOSTATIN RECEPTOR 2; SSTR2
185250 MATRIX METALLOPROTEINASE 3; MMP3
186720 CD6 ANTIGEN; CD6
191160 TUMOR NECROSIS FACTOR; TNF
202700 NEUTROPENIA, SEVERE CONGENITAL; SCN
211980 LUNG CANCER
216400 COCKAYNE SYNDROME, TYPE A; CSA
220120 D-GLYCERIC ACIDEMIA
220900 DEAFNESS, CONGENITAL, WITH TOTAL ALBINISM
222600 DIASTROPHIC DYSPLASIA
226900 EPIPHYSEAL DYSPLASIA, MULTIPLE, 4; EDM4
250250 CARTILAGE-HAIR HYPOPLASIA; CHH
264480 PSEUDOTRISOMY 13 SYNDROME
310500 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1A; CSNB1A
600168 MACROPHAGE STIMULATING 1 RECEPTOR; MST1R
600726 INDIAN HEDGEHOG; IHH
600807 ASTHMA, SUSCEPTIBILITY TO
601139 ZINC FINGER PROTEIN 175; ZNF175
601231 FKBP12-RAPAMYCIN COMPLEX-ASSOCIATED PROTEIN 1; FRAP1
601512 SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 6; STAT6
601652 MYOCILIN; MYOC
601662 ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; ALCAM
601682 GLAUCOMA 1, OPEN ANGLE, C; GLC1C
602432 OPTINEURIN; OPTN
602436 MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I CHAIN-RELATED GENE B; MICB
602471 SHORT STATURE, AUDITORY CANAL ATRESIA, MANDIBULAR HYPOPLASIA, SKELETAL
602893 KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY C, MEMBER 4; KLRC4
603380 LIN7, C. ELEGANS, HOMOLOG A; LIN7A
603415 SODIUM CHANNEL, VOLTAGE-GATED, TYPE IX, ALPHA SUBUNIT; SCN9A
604515 B-CELL LINKER PROTEIN; BLNK
605286 CALPAIN 10; CAPN10
606195 IROQUOIS HOMEOBOX PROTEIN 5; IRX5
606196 IROQUOIS HOMEOBOX PROTEIN 6; IRX6
606197 IROQUOIS HOMEOBOX PROTEIN 1; IRX1
606198 IROQUOIS HOMEOBOX PROTEIN 2; IRX2
606199 IROQUOIS HOMEOBOX PROTEIN 4; IRX4
606202 MEMBRANE-ASSOCIATED TRANSPORTER PROTEIN; MATP
606718 SOLUTE CARRIER FAMILY 26 (SULFATE TRANSPORTER), MEMBER 2; SLC26A2
606784 GLYCOGEN SYNTHASE KINASE 3-ALPHA; GSK3A
607095 ANAUXETIC DYSPLASIA
607340 GAMMA-AMINOBUTYRIC ACID B RECEPTOR 2; GABBR2
608175 AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 3
608622 HYPERTENSION, DIASTOLIC, RESISTANCE TO
608798 DFNA5 GENE; DFNA5
608874 OROFACIAL CLEFT 5
609412 EXCISION-REPAIR CROSS-COMPLEMENTING, GROUP 8; ERCC8
609581 MOVED TO 130720
610414 NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 15; NBPF15
610496 RHO GTPase-ACTIVATING PROTEIN 29; ARHGAP29
610499 RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 6; RAPGEF6
610514 PHD FINGER PROTEIN 17; PHF17
610516 GLYCERATE KINASE; GLYCTK
610517 CONTACTN-ASSOCIATED PROTEIN-LIKE 3; CNTNAP3
610518 CONTACTIN-ASSOCIATED PROTEIN-LIKE 4; CNTNAP4
610519 CONTACTIN-ASSOCIATED PROTEIN-LIKE 5; CNTNAP5
Clinical Synopsis for 137920 RENAL CYSTS AND DIABETES SYNDROME
Clinical Synopsis for 245150 KEUTEL SYNDROME
Clinical Synopsis for 250460 METAPHYSEAL DYSPLASIA WITHOUT HYPOTRICHOSIS
Clinical Synopsis for 255320 MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA
Clinical Synopsis for 601152 HEREDITARY MOTOR AND SENSORY NEUROPATHY VI
Clinical Synopsis for 605839 LEIOMYOMATOSIS AND RENAL CELL CANCER, HEREDITARY
Clinical Synopsis for 606528 HOMOZYGOUS 11p15-p14 DELETION SYNDROME

October 23, 2006

New Entries:

608765 SCOLIOSIS, IDIOPATHIC 3; IS3
608798 DFNA5 GENE; DFNA5

Changed Entries:

120110 COLLAGEN, TYPE X, ALPHA-1; COL10A1
121014 GAP JUNCTION PROTEIN, ALPHA-1; GJA1
128100 DYSTONIA, TORSION, 1, AUTOSOMAL DOMINANT; DYT1
128230 DYSTONIA, DOPA-RESPONSIVE; DRD
141900 HEMOGLOBIN--BETA LOCUS; HBB
145250 HYPERPIGMENTATION, FAMILIAL PROGRESSIVE
147450 SUPEROXIDE DISMUTASE 1; SOD1
147470 INSULIN-LIKE GROWTH FACTOR II; IGF2
164200 OCULODENTODIGITAL DYSPLASIA; ODDD
176263 POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, MEMBER
181800 SCOLIOSIS, IDIOPATHIC; IS1
201300 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II; HSAN2
235200 HEMOCHROMATOSIS; HFE
259050 OSSIFIED EAR CARTILAGES WITH MENTAL DEFICIENCY, MUSCLE WASTING, AND
400017 THYMOSIN, BETA-4, Y CHROMOSOME; TMSB4Y
600225 GTP CYCLOHYDROLASE I; GCH1
600487 PROPROTEIN CONVERTASE, SUBTILISIN/KEXIN-TYPE, 4; PCSK4
600778 CYCLIN-DEPENDENT KINASE INHIBITOR 1B; CDKN1B
600994 DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 5; DFNA5
601510 SREBP CLEAVAGE-ACTIVATING PROTEIN
605204 TORSIN-A; DYT1
605717 INDUCIBLE T-CELL COSTIMULATOR LIGAND; ICOSLG
606270 TOLL-LIKE RECEPTOR 10; TLR10
606634 DERMCIDIN; DCD
607354 SCOLIOSIS, IDIOPATHIC 2; IS2
608714 SYNTROPHIN, GAMMA-1; SNTG1
608798 DFNA5 GENE; DFNA5

October 20, 2006

New Entries:

610501 NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 1; NBPF1
610511 SEC23, S. CEREVISIAE, HOMOLOG OF, A; SEC23A
610512 SEC23, S. CEREVISIAE, HOMOLOG OF, B; SEC23B
610513 ATPase, TYPE 13A2; ATP13A2

Changed Entries:

113705 BREAST CANCER 1 GENE; BRCA1
124080 CYTOCHROME P450, SUBFAMILY XIB, POLYPEPTIDE 2; CYP11B2
125220 DEFENSIN, ALPHA, 1; DEFA1
131100 MULTIPLE ENDOCRINE NEOPLASIA, TYPE I; MEN1
136435 FOLLICLE-STIMULATING HORMONE RECEPTOR; FSHR
138850 GONADOTROPIN-RELEASING HORMONE RECEPTOR; GNRHR
142900 HOLT-ORAM SYNDROME; HOS
147781 INTERLEUKIN 4 RECEPTOR; IL4R
181450 ULNAR-MAMMARY SYNDROME; UMS
191525 URACIL-DNA GLYCOSYLASE; UNG
232300 GLYCOGEN STORAGE DISEASE II
257220 NIEMANN-PICK DISEASE, TYPE C1; NPC1
300193 HIGH MOBILITY GROUP BOX 3; HMGB3
300490 SH2 DOMAIN PROTEIN 1A; SH2D1A
601620 T-BOX 5; TBX5
601621 T-BOX 3; TBX3
602726 CHLORIDE CHANNEL 6; CLCN6
604522 DEFENSIN, ALPHA, 3; DEFA3
605004 GLYCOGEN SYNTHASE KINASE 3-BETA; GSK3B
605554 CD244 ANTIGEN; CD244
606784 GLYCOGEN SYNTHASE KINASE 3-ALPHA; GSK3A
606800 GLUCOSIDASE, ALPHA, ACID; GAA
607623 NPC1 GENE; NPC1
610511 SEC23, S. CEREVISIAE, HOMOLOG OF, A; SEC23A

October 19, 2006

New Entries:

610510 AURORA BOREALIS

Changed Entries:

114210 S100 CALCIUM-BINDING PROTEIN A4; S100A4
124010 CYTOCHROME P450, SUBFAMILY IIIA, POLYPEPTIDE 4; CYP3A4
124015 CYTOCHROME P450 OXIDOREDUCTASE; POR
138079 GLUCOKINASE; GCK
142410 TRANSCRIPTION FACTOR 1; TCF1
145900 HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS
147740 INTERLEUKIN 3; IL3
151385 RUNT-RELATED TRANSCRIPTION FACTOR 1; RUNX1
154545 LECTIN, MANNOSE-BINDING, SOLUBLE, 2; MBL2
176915 PROTEIN PHOSPHATASE 2, CATALYTIC SUBUNIT, ALPHA ISOFORM; PPP2CA
176990 S100 CALCIUM-BINDING PROTEIN, BETA; S100B
180660 POLYMERASE II, RNA, SUBUNIT A; POLR2A
182452 SOMATOSTATIN RECEPTOR 2; SSTR2
185800 SYMPHALANGISM, PROXIMAL; SYM1
191170 TUMOR PROTEIN p53; TP53
191525 URACIL-DNA GLYCOSYLASE; UNG
201750 ADRENAL HYPERPLASIA, CONGENITAL, DUE TO APPARENT COMBINED P450C17
250220 METAPHYSEAL CHONDRODYSPLASIA, CONGENITAL LETHAL
253310 LETHAL CONGENITAL CONTRACTURE SYNDROME 1
600281 HEPATOCYTE NUCLEAR FACTOR 4-ALPHA; HNF4A
601047 CAVEOLIN 1; CAV1
601146 GROWTH/DIFFERENTIATION FACTOR 5; GDF5
601769 VITAMIN D RECEPTOR; VDR
602466 SPROUTY, DROSOPHILA, HOMOLOG OF, 2; SPRY2
602926 SYNTAXIN-BINDING PROTEIN 1; STXBP1
603072 AURORA KINASE A; AURKA
603243 AUTOCRINE MOTILITY FACTOR RECEPTOR; AMFR
603507 LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 6; LRP6
603795 LIPOPOLYSACCHARIDE-INDUCED TUMOR NECROSIS FACTOR-ALPHA FACTOR; LITAF
604147 PITUITARY TUMOR-TRANSFORMING GENE 1; PTTG1
605253 NEUROPATHY, CONGENITAL HYPOMYELINATING
605523 TRANSDUCER OF ERBB2, 1; TOB1
606359 WINGLESS-TYPE MMTV INTEGRATION SITE FAMILY, MEMBER 3A; WNT3A
607358 AUTOIMMUNE REGULATOR; AIRE
607393 HRPT2 GENE; HRPT2
607752 URACIL-DNA GLYCOSYLASE 2; UNG2
607984 SPROUTY, DROSOPHILA, HOMOLOG OF, 4; SPRY4
608736 SOLUTE CARRIER FAMILY 39 (ZINC TRANSPORTER), MEMBER 14; SLC39A14
609366 SH2 DOMAIN-BINDING PROTEIN 1; SH2BP1
609708 LIPOPROTEIN LIPASE; LPL
610453 HEPARAN-ALPHA-GLUCOSAMINIDE N-ACETYLTRANSFERASE; HGSNAT

October 18, 2006

New Entries:

610475 PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2; PPNAD2
610489 PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1; PPNAD1
610498 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2
610504 PRETERM PREMATURE RUPTURE OF THE MEMBRANES; PPROM
610505 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3; COXPD3
610506 PAF1 RNA POLYMERASE II-ASSOCIATED FACTOR, S. CEREVISIAE, HOMOLOG OF;
610507 LEO1 RNA POLYMERASE II ASSOCIATED FACTOR, S. CEREVISIAE, HOMOLOG OF;
610508 MATURITY-ONSET DIABETES OF THE YOUNG, TYPE VII; MODY7
610509 RESISTANCE TO INHIBITORS OF CHOLINESTERASE 3, C. ELEGANS, HOMOLOG

Changed Entries:

104300 ALZHEIMER DISEASE; AD
104760 AMYLOID BETA A4 PRECURSOR PROTEIN; APP
114840 CARBOXYL-ESTER LIPASE; CEL
120355 MATRIX METALLOPROTEINASE 8; MMP8
125520 CAYLER CARDIOFACIAL SYNDROME
139320 GNAS COMPLEX LOCUS; GNAS
143200 WAGNER SYNDROME 1; WGN1
154780 MARSHALL SYNDROME
156225 LAMININ, ALPHA-2; LAMA2
160980 CARNEY COMPLEX, TYPE 1; CNC1
165240 GLI-KRUPPEL FAMILY MEMBER 3; GLI3
168450 PARATHYROID HORMONE; PTH
188830 PROTEIN KINASE, cAMP-DEPENDENT, REGULATORY, TYPE I, ALPHA; PRKAR1A
191525 URACIL-DNA GLYCOSYLASE; UNG
201300 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II; HSAN2
219080 ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH
246570 FIBULAR APLASIA, TIBIAL CAMPOMELIA, AND OLIGOSYNDACTYLY SYNDROME
300286 KRUPPEL-LIKE FACTOR 8; KLF8
310500 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1A; CSNB1A
600047 ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 2; ABCA2
600943 COLLAGEN-BINDING PROTEIN 2; CBP2
601653 EYES ABSENT 1; EYA1
601769 VITAMIN D RECEPTOR; VDR
602568 METHIONINE SYNTHASE REDUCTASE; MTRR
603301 KRUPPEL-LIKE FACTOR 11; KLF11
604723 Ts TRANSLATION ELONGATION FACTOR, MITOCHONDRIAL; TSFM
604961 PHOSPHODIESTERASE 11A; PDE11A
606391 MATURITY-ONSET DIABETES OF THE YOUNG; MODY
606594 SET DOMAIN-CONTAINING PROTEIN 7; SETD7
607240 SET DOMAIN-CONTAINING PROTEIN 8; SETD8
607393 HRPT2 GENE; HRPT2
607752 URACIL-DNA GLYCOSYLASE 2; UNG2
607855 MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A
608620 HSN2 GENE; HSN2
609060 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1; COXPD1
609204 MITOCHONDRIAL RIBOSOMAL PROTEIN S16: MRPS16
609366 SH2 DOMAIN-BINDING PROTEIN 1; SH2BP1
609812 MATURITY-ONSET DIABETES OF THE YOUNG, TYPE VIII, WITH EXOCRINE DYSFUNCTION;
610475 PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2; PPNAD2
610504 PRETERM PREMATURE RUPTURE OF THE MEMBRANES; PPROM
610506 PAF1 RNA POLYMERASE II-ASSOCIATED FACTOR, S. CEREVISIAE, HOMOLOG OF;
610509 RESISTANCE TO INHIBITORS OF CHOLINESTERASE 3, C. ELEGANS, HOMOLOG
Clinical Synopsis for 143200 WAGNER SYNDROME 1; WGN1

October 17, 2006

New Entries:

610500 ANKYRIN REPEAT AND KH DOMAIN-CONTAINING PROTEIN 1; ANKHD1
610502 RETICULON 4-INTERACTING PROTEIN 1; RTN4IP1
610503 CHROMOSOME 16 OPEN READING FRAME 5; C16ORF5

Changed Entries:

113505 BRAIN-DERIVED NEUROTROPHIC FACTOR; BDNF
138275 GLUTAMIC ACID DECARBOXYLASE 2; GAD2
143023 RAS ASSOCIATION DOMAIN FAMILY, MEMBER 7; RASSF7
182340 ATPase, Na+/K+ TRANSPORTING, ALPHA-2 POLYPEPTIDE; ATP1A2
219090 CUSHING DISEASE, PITUITARY
601510 SREBP CLEAVAGE-ACTIVATING PROTEIN
602695 TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 12; TNFSF12
602974 AQUAPORIN 7; AQP7
603483 EUKARYOTIC TRANSLATION INITIATION FACTOR 4E-BINDING PROTEIN 3; EIF4EBP3
604386 ZINC FINGER TRANSCRIPTION FACTOR TRPS1; TRPS1
604472 TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 13; TNFSF13
604882 NEUROGENIN 3; NEUROG3
604907 TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 13B; TNFRSF13B
605244 CARNEY COMPLEX, TYPE II; CNC2
606624 NEUROGENIN 2; NEUROG2
607173 PROTEASOME 26S SUBUNIT, NON-ATPase, 14; PSMD14
608231 RAS ASSOCIATION DOMAIN FAMILY, MEMBER 8; RASSF8
610222 RAS AND RAB INTERACTOR 2; RIN2
610399 TRANSMEMBRANE PROTEASE, SERINE 11E; TMPRSS11E
610414 NEUROBLASTOMA BREAKPOINT FAMILY, MEMBER 15; NBPF15
610448 CHILBLAIN LUPUS
610499 RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 6; RAPGEF6

October 16, 2006

New Entries:

300617 BRCA1/BRCA2-CONTAINING COMPLEX, SUBUNIT 3; BRCC3
610494 IQ MOTIF- AND WD REPEATS-CONTAINING 1; IQWD1
610495 HOM-TES-103 GENE
610496 RHO GTPase-ACTIVATING PROTEIN 29; ARHGAP29
610497 BRAIN AND REPRODUCTIVE ORGAN-EXPRESSED PROTEIN; BRE
610499 RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 6; RAPGEF6

Changed Entries:

108300 STICKLER SYNDROME, TYPE I; STL1
112262 BONE MORPHOGENETIC PROTEIN 4; BMP4
113705 BREAST CANCER 1 GENE; BRCA1
118423 CHIMERIN 1; CHN1
118661 CHONDROITIN SULFATE PROTEOGLYCAN 2; CSPG2
120140 COLLAGEN, TYPE II, ALPHA-1; COL2A1
123900 VILLIN 2; VIL2
137240 GASTRIC INHIBITORY POLYPEPTIDE; GIP
143200 WAGNER SYNDROME 1; WGN1
152390 ARACHIDONATE 5-LIPOXYGENASE; ALOX5
179617 RAD51, S. CEREVISIAE, HOMOLOG OF; RAD51
300023 RHO GTPase-ACTIVATING PROTEIN 4; ARHGAP4
300116 MATURE T-CELL PROLIFERATION 1; MTCP1
300118 RHO GTPase-ACTIVATING PROTEIN 6; ARHGAP6
300617 BRCA1/BRCA2-CONTAINING COMPLEX, SUBUNIT 3; BRCC3
306700 HEMOPHILIA A
600185 BREAST CANCER 2 GENE; BRCA2
600303 RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 1; RAPGEF1
601593 BRCA1-ASSOCIATED RING DOMAIN 1; BARD1
602632 PODOCALYXIN-LIKE; PODXL
602680 RHO GTPase-ACTIVATING PROTEIN 5; ARHGAP5
602732 RHO GTPase-ACTIVATING PROTEIN 1; ARHGAP1
602857 CHIMERIN 2; CHN2
603594 TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY, MEMBER 4; TNFSF4
604258 DELETED IN LIVER CANCER 1; DLC1
605370 RHO GTPase-ACTIVATING PROTEIN 26; ARHGAP26
606523 SLIT-ROBO RHO GTPase-ACTIVATING PROTEIN 1; SRGAP1
606524 SLIT-ROBO RHO GTPase-ACTIVATING PROTEIN 2; SRGAP2
606525 SLIT-ROBO RHO GTPase-ACTIVATING PROTEIN 3; SRGAP3
606553 SOLUTE CARRIER FAMILY 9, ISOFORM 3, REGULATORY FACTOR 2; SLC9A3R2
606748 COACTOSIN-LIKE PROTEIN 1; COTL1
608293 RHO GTPase-ACTIVATING PROTEIN 17; ARHGAP17
609405 RHO GTPase-ACTIVATING PROTEIN 8; ARHGAP8
609508 STICKLER SYNDROME, TYPE I, NONSYNDROMIC OCULAR
609568 RHO GTPase-ACTIVATING PROTEIN 20; ARHGAP20
609746 RHO GTPase-ACTIVATING PROTEIN 10; ARHGAP10
609870 RHO GTPase-ACTIVATING PROTEIN 21; ARHGAP21
610351 MEK1 SUPPRESSOR 1
610352 MEK1 SUPPRESSOR 2
610492 SLAIN MOTIF FAMILY, MEMBER 2; SLAIN2
610494 IQ MOTIF- AND WD REPEATS-CONTAINING 1; IQWD1
610496 RHO GTPase-ACTIVATING PROTEIN 29; ARHGAP29

October 13, 2006

New Entries:

300616 LEUCINE ZIPPER PROTEIN 4; LUZP4
610488 TETRATRICOPEPTIDE REPEAT DOMAIN 9; TTC9
610490 PURPLE ACID PHOSPHATASE, LONG FORM
610491 SLAIN MOTIF FAMILY, MEMBER 1; SLAIN1
610492 SLAIN MOTIF FAMILY, MEMBER 2; SLAIN2
610493 DIX DOMAIN-CONTAINING PROTEIN 1; DIXDC1

Changed Entries:

103500 TIETZ SYNDROME
104311 PRESENILIN 1; PSEN1
114180 CALMODULIN 1; CALM1
120160 COLLAGEN, TYPE I, ALPHA-2; COL1A2
125647 DESMOPLAKIN; DSP
154700 MARFAN SYNDROME; MFS
156845 MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; MITF
176270 PRADER-WILLI SYNDROME; PWS
179520 RAS-RELATED PROTEIN 1A; RAP1A
179540 RAS-RELATED PROTEIN 2A; RAP2A
179541 RAS-RELATED PROTEIN 2B; RAP2B
187300 TELANGIECTASIA, HEREDITARY HEMORRHAGIC, OF RENDU, OSLER, AND WEBER;
225320 EHLERS-DANLOS SYNDROME, AUTOSOMAL RECESSIVE, CARDIAC VALVULAR FORM
235730 MOWAT-WILSON SYNDROME
300290 INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA
300401 PROTEOLIPID PROTEIN 1; PLP1
300461 ORNITHINE CARBAMOYLTRANSFERASE; OTC
306700 HEMOPHILIA A
600005 MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, TRANSACTIVATOR; MHC2TA
601692 TRANSFORMING GROWTH FACTOR, BETA-INDUCED, 68-KD; TGFBI
602489 KH DOMAIN-CONTAINING, RNA-BINDING, SIGNAL TRANSDUCTION-ASSOCIATED
602612 CAMPTODACTYLY, MYOPIA, AND FIBROSIS OF THE MEDIAL RECTUS MUSCLE OF
603381 FILAMIN B; FLNB
605802 ZINC FINGER HOMEOBOX 1B; ZFHX1B
605946 METAPHYSEAL DYSPLASIA, BRAUN-TINSCHERT TYPE
606419 PRECURSOR mRNA-PROCESSING FACTOR 31, S. CEREVISIAE, HOMOLOG OF; PRPF31
606478 PROTECTION OF TELOMERES 1; POT1
607086 AORTIC ANEURYSM, FAMILIAL THORACIC 1
609449 NUDE, A. NIDULANS, HOMOLOG OF, 1; NDE1
609546 UBIQUITIN-SPECIFIC PROTEASE 29; USP29
610126 MICROPHTHALMIA, SYNDROMIC 6; MCOPS6
610381 CONE-ROD DYSTROPHY 11
610421 KH DOMAIN-CONTAINING, RNA-BINDING, SIGNAL TRANSDUCTION-ASSOCIATED
610493 DIX DOMAIN-CONTAINING PROTEIN 1; DIXDC1

October 12, 2006

New Entries:

610483 AGAMMAGLOBULINEMIA, MICROCEPHALY, AND SEVERE DERMATITIS
610484 PROLINE-RICH SYNAPSE-ASSOCIATED PROTEIN-INTERACTING PROTEIN 1
610485 LOSS OF HETEROZYGOSITY, CHROMOSOME 3, REGION 2, GENE A; LOH3CR2A
610486 LEUCINE-RICH REPEAT-CONTAINING PROTEIN 4; LRRC4
610487 KH DOMAIN-CONTAINING, RNA-BINDING, SIGNAL TRANSDUCTION-ASSOCIATED

Changed Entries:

101200 APERT SYNDROME
103070 ADENYLATE CYCLASE 8; ADCY8
103071 ADENYLATE CYCLASE 2; ADCY2
103072 ADENYLATE CYCLASE 1; ADCY1
108985 SVEINSSON CHORIORETINAL ATROPHY; SCRA
114500 COLORECTAL CANCER; CRC
118502 CHOLINERGIC RECEPTOR, NEURONAL NICOTINIC, ALPHA POLYPEPTIDE 2; CHRNA2
120290 COLLAGEN, TYPE XI, ALPHA-2; COL11A2
125853 DIABETES MELLITUS, NONINSULIN-DEPENDENT; NIDDM
133780 EXUDATIVE VITREORETINOPATHY 1; EVR1
153700 MACULAR DYSTROPHY, VITELLIFORM; VMD
153870 MACULAR DYSTROPHY, CONCENTRIC ANNULAR
163200 NEVUS SEBACEUS OF JADASSOHN
163730 NITRIC OXIDE SYNTHASE 2A; NOS2A
182940 NEURAL TUBE DEFECTS
191390 ULCERATIVE COLITIS, SUSCEPTIBILITY TO
193235 VITREORETINOPATHY, NEOVASCULAR INFLAMMATORY; VRNI
194050 WILLIAMS-BEUREN SYNDROME; WBS
215150 OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA; OSMED
257270 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B; CSNB1B
266600 INFLAMMATORY BOWEL DISEASE 1; IBD1
300476 CONE-ROD DYSTROPHY, X-LINKED, 3; CORDX3
300614 AUDITORY NEUROPATHY, X-LINKED, 1, WITH PERIPHERAL NEUROPATHY
301040 ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, NONDELETION TYPE, X-LINKED;
309801 MICROPHTHALMIA, SYNDROMIC 7; MCOPS7
310500 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1A; CSNB1A
600037 ORTHODENTICLE, DROSOPHILA, HOMOLOG OF, 2; OTX2
600045 DNA DAMAGE-BINDING PROTEIN 1; DDB1
600291 ADENYLATE CYCLASE 3; ADCY3
600292 ADENYLATE CYCLASE 4; ADCY4
600293 ADENYLATE CYCLASE 5; ADCY5
600294 ADENYLATE CYCLASE 6; ADCY6
600385 ADENYLATE CYCLASE 7; ADCY7
600807 ASTHMA, SUSCEPTIBILITY TO
601276 ZINC FINGER PROTEIN 177; ZNF177
601401 MYELOID LEUKEMIA FACTOR 2; MLF2
601424 3-@OXOACID CoA TRANSFERASE 1; OXCT1
602489 KH DOMAIN-CONTAINING, RNA-BINDING, SIGNAL TRANSDUCTION-ASSOCIATED
602929 LOSS OF HETEROZYGOSITY, CHROMOSOME 11, REGION 2, GENE A; LOH11CR2A
602932 MOTHERS AGAINST DECAPENTAPLEGIC, DROSOPHILA, HOMOLOG OF, 7; SMAD7
603037 LEFT-RIGHT DETERMINATION FACTOR 1; LEFTY1
603045 LOSS OF HETEROZYGOSITY, CHROMOSOME 18, REGION 1; LOH18CR1
603075 MACULAR DEGENERATION, AGE-RELATED, 1; ARMD1
603104 CARBOXYPEPTIDASE N, POLYPEPTIDE 2, 83-KD; CPN2
603302 ADENYLATE CYCLASE 9; ADCY9
603513 CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE
604096 GLUTAMATE RECEPTOR, METABOTROPIC, 6; GRM6
604213 CHUDLEY-MCCULLOUGH SYNDROME
604519 INFLAMMATORY BOWEL DISEASE 3; IBD3
605300 ADAPTOR PROTEIN CONTAINING PH AND SH2 DOMAINS
607076 PROTEASE INHIBITOR 15; PI15
607335 BESTROPHIN 2; BEST2
607336 BESTROPHIN 4; BEST4
607337 BESTROPHIN 3; BEST3
607485 FRONTOTEMPORAL DEMENTIA, UBIQUITIN-POSITIVE
607854 BESTROPHIN 1; BEST1
607948 MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO INFECTION BY
608161 MACULAR DYSTROPHY, VITELLIFORM, ADULT-ONSET
608329 CHROMOSOME 11 OPEN READING FRAME 9; C11ORF9
608505 MOVED TO 225750
608603 CANCER-RELATED GENE, LIVER, 2
609532 HEPATITIS C VIRUS, SUSCEPTIBILITY TO
609622 SHORT QT SYNDROME 3; SQT3
610247 ESOPHAGITIS, EOSINOPHILIC
610273 PHOSPHATIDYLINOSITOL GLYCAN, CLASS M; PIGM
610274 PHOSPHATIDYLINOSITOL GLYCAN, CLASS V; PIGV
610275 PHOSPHATIDYLINOSITOL GLYCAN, CLASS W; PIGW
610293 GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY
610324 3-@OXOACYL-ACP SYNTHASE, MITOCHONDRIAL; OXSM
610331 HAIRY/ENHANCER OF SPLIT, DROSOPHILA, HOMOLOG OF, 6; HES6
610353 EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 4
610362 RETINA AND ANTERIOR NEURAL FOLD HOMEOBOX-LIKE 1; RAXL1
610371 SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER
610374 DIABETES MELLITUS, TRANSIENT NEONATAL, 2
610379 WEST NILE VIRUS, SUSCEPTIBILITY TO
610380 AORTIC ANEURYSM, FAMILIAL THORACIC 5
610386 BTB/POX DOMAIN-CONTAINING PROTEIN 7; BTBD7
610424 HEPATITIS B VIRUS, SUSCEPTIBILITY TO
610474 CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME
610476 ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 11; ARVD11
610478 RETINAL CONE DYSTROPHY 4; RCD4

October 11, 2006

New Entries:

610460 THIOPURINE S-METHYLTRANSFERASE DEFICIENCY
610477 TRANSMEMBRANE PROTEASE, SERINE 9; TMPRSS9
610479 SRF-DEPENDENT TRANSCRIPTION REGULATION-ASSOCIATED PROTEIN; SRFBP1
610480 LEM DOMAIN-CONTAINING PROTEIN 1; LEMD1
610481 SH2 DOMAIN-CONTAINING PROTEIN D; SHD
610482 SH2 DOMAIN-CONTAINING PROTEIN E; SHE

Changed Entries:

102560 ACTIN, GAMMA-1; ACTG1
102630 ACTIN, BETA; ACTB
104760 AMYLOID BETA A4 PRECURSOR PROTEIN; APP
120577 COMPLEMENT COMPONENT 1, q SUBCOMPONENT, RECEPTOR 1; C1QR1
130050 EHLERS-DANLOS SYNDROME, TYPE IV, AUTOSOMAL DOMINANT
131230 ANNEXIN A5; ANXA5
138190 SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER
163730 NITRIC OXIDE SYNTHASE 2A; NOS2A
169610 PEMPHIGUS VULGARIS, FAMILIAL
180860 SILVER-RUSSELL SYNDROME; SRS
187680 THIOPURINE S-METHYLTRANSFERASE; TPMT
190181 TRANSFORMING GROWTH FACTOR-BETA RECEPTOR, TYPE I; TGFBR1
190182 TRANSFORMING GROWTH FACTOR-BETA RECEPTOR, TYPE II; TGFBR2
191160 TUMOR NECROSIS FACTOR; TNF
248190 HYPOMAGNESEMIA, RENAL, WITH OCULAR INVOLVEMENT
254940 MYOPATHY, CONGENITAL NONPROGRESSIVE, WITH MOEBIUS SEQUENCE AND ROBIN
256600 NEUROAXONAL DYSTROPHY, INFANTILE; INAD1
300300 BRUTON AGAMMAGLOBULINEMIA TYROSINE KINASE; BTK
300394 TAFAZZIN; TAZ
302060 BARTH SYNDROME; BTHS
600073 LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 2; LRP2
600289 MITOGEN-ACTIVATED PROTEIN KINASE 14; MAPK14
600385 ADENYLATE CYCLASE 7; ADCY7
600970 MYOSIN VI; MYO6
602081 SPEECH-LANGUAGE DISORDER 1; SPCH1
602382 PHOSPHOLIPASE D1, PHOSPHATIDYLCHOLINE-SPECIFIC; PLD1
603301 TRANSFORMING GROWTH FACTOR-BETA-INDUCIBLE EARLY GROWTH RESPONSE 2;
603372 THYROID-STIMULATING HORMONE RECEPTOR; TSHR
603604 PHOSPHOLIPASE A2, GROUP VI; PLA2G6
605072 GAIP C-TERMINUS-INTERACTING PROTEIN 1; GIPC1
605317 FORKHEAD BOX P2; FOXP2
605857 RAS HOMOLOG GENE FAMILY, MEMBER Q; ARHQ
606409 ITCHY, MOUSE, HOMOLOG OF; ITCH
607844 LEM DOMAIN-CONTAINING PROTEIN 3; LEMD3
609192 LOEYS-DIETZ SYNDROME; LDS
610168 FURLONG SYNDROME: FS
Clinical Synopsis for 309801 MICROPHTHALMIA, SYNDROMIC 7; MCOPS7

October 10, 2006

New Entries:

610471 VASOHIBIN 2; VASH2
610472 ACYLTRANSFERASE-LIKE 2; AYTL2
610473 LYSOPHOSPHATIDYLGLYCEROL ACYLTRANSFERASE 1; LPGAT1
610474 CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME
610476 ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 11; ARVD11
610478 RETINAL CONE DYSTROPHY 4; RCD4

Changed Entries:

107970 ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 1; ARVD1
117000 CENTRAL CORE DISEASE OF MUSCLE
120436 MutL, E. COLI, HOMOLOG OF, 1; MLH1
125645 DESMOCOLLIN 2; DSC2
134934 FIBROBLAST GROWTH FACTOR RECEPTOR 3; FGFR3
138030 GLUCAGON; GCG
164840 V-MYC AVIAN MYELOCYTOMATOSIS VIRAL-RELATED ONCOGENE, NEUROBLASTOMA-DERIVED;
179040 MOVED TO 179050
180901 RYANODINE RECEPTOR 1; RYR1
182135 5-@HYDROXYTRYPTAMINE RECEPTOR 2A; HTR2A
248190 HYPOMAGNESEMIA, RENAL, WITH OCULAR INVOLVEMENT
248250 HYPOMAGNESEMIA, PRIMARY
252930 MUCOPOLYSACCHARIDOSIS TYPE IIIC
300056 HOLOCYTOCHROME C SYNTHASE; HCCS
309801 MICROPHTHALMIA, SYNDROMIC 7; MCOPS7
600778 CYCLIN-DEPENDENT KINASE INHIBITOR 1B; CDKN1B
601728 PHOSPHATASE AND TENSIN HOMOLOG; PTEN
602372 ZONADHESIN; ZAN
602712 AMYLOID BETA A4 PRECURSOR PROTEIN-BINDING, FAMILY A, MEMBER 2; APBA2
603369 CYCLIN-DEPENDENT KINASE INHIBITOR 2C; CDKN2C
603452 MOVED TO 602712
604605 KALIRIN; KALRN
604723 Ts TRANSLATION ELONGATION FACTOR, MITOCHONDRIAL; TSFM
604934 TUBULIN-SPECIFIC CHAPERONE E; TBCE
605723 PROGRAMMED CELL DEATH 1 LIGAND 2; PDCD1LG2
606478 PROTECTION OF TELOMERES 1; POT1
606639 MITOCHONDRIAL ELONGATION FACTOR G1; GFM1
607145 DYSTROBREVIN-BINDING PROTEIN 1; DTNBP1
608171 CALCIUM CHANNEL, VOLTAGE-DEPENDENT, ALPHA-2/DELTA SUBUNIT 4; CACNA2D4
608309 PTEN-INDUCED PUTATIVE KINASE 1; PINK1
609011 VASOHIBIN 1; VASH1
609060 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1
610036 CLAUDIN 19; CLDN19
610453 HEPARAN-ALPHA-GLUCOSAMINIDE N-ACETYLTRANSFERASE; HGSNAT

October 9, 2006

New Entries:

610468 INTERFERON-INDUCED PROTEIN 44; IFI44
610469 ADAPTOR-RELATED PROTEIN COMPLEX 3, MU-2 SUBUNIT; AP3M2
610470 TRANSFER RNA PHOSPHOTRANSFERASE 1; TRPT1

Changed Entries:

114500 COLORECTAL CANCER; CRC
147470 INSULIN-LIKE GROWTH FACTOR II; IGF2
147586 INTERFERON-GAMMA-INDUCIBLE PROTEIN 16; IFI16
163200 NEVUS SEBACEUS OF JADASSOHN
168461 CYCLIN D1; CCND1
174900 JUVENILE POLYPOSIS SYNDROME; JPS
175100 ADENOMATOUS POLYPOSIS OF THE COLON; APC
176730 INSULIN; INS
180901 RYANODINE RECEPTOR 1; RYR1
191290 TYROSINE HYDROXYLASE; TH
194554 ZINC FINGER PROTEIN 45; ZNF45
194555 ZINC FINGER PROTEIN 224; ZNF224
228250 FEMUR, UNILATERAL BIFID, WITH MONODACTYLOUS ECTRODACTYLY
300120 CHROMOSOME X OPEN READING FRAME 6; CXORF6
300171 MYOTUBULARIN-RELATED PROTEIN 1; MTMR1
305620 FRONTOMETAPHYSEAL DYSPLASIA; FMD
310400 MYOTUBULAR MYOPATHY 1; MTM1
516060 ATP SYNTHASE 6; MTATP6
600879 NUCLEAR RESPIRATORY FACTOR 1; NRF1
600993 MOTHERS AGAINST DECAPENTAPLEGIC, DROSOPHILA, HOMOLOG OF, 4; SMAD4
601158 MITOGEN-ACTIVATED PROTEIN KINASE 8; MAPK8
601206 POU DOMAIN, CLASS 2, ASSOCIATING FACTOR 1; POU2AF1
601742 TRIPARTITE MOTIF-CONTAINING PROTEIN 28; TRIM28
601767 HUNTINGTIN-INTERACTING PROTEIN 1; HIP1
601781 MOVED TO 194554
602279 POLYADENYLATE-BINDING PROTEIN, NUCLEAR, 1; PABPN1
602372 ZONADHESIN; ZAN
602614 MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 7; MAP3K7
604373 CHECKPOINT KINASE 2, S. POMBE, HOMOLOG OF; CHEK2
606681 NUCLEAR RECEPTOR-BINDING Su-var, ENHANCER OF ZESTE, AND TRITHORAX
606955 MOVED TO 194555
606956 ZINC FINGER PROTEIN 256; ZNF256
610366 ADAPTOR-RELATED PROTEIN COMPLEX 3, MU-1 SUBUNIT; AP3M1
610469 ADAPTOR-RELATED PROTEIN COMPLEX 3, MU-2 SUBUNIT; AP3M2
610470 TRANSFER RNA PHOSPHOTRANSFERASE 1; TRPT1

October 6, 2006

New Entries:

610464 G PROTEIN-COUPLED RECEPTOR 156; GPR156
610466 LIMB EXPRESSION 1, MOUSE, HOMOLOG OF; LIX1
610467 PROTEIN TYROSINE PHOSPHATASE-LIKE (PROLINE INSTEAD OF CATALYTIC ARGININE),

Changed Entries:

107741 APOLIPOPROTEIN E; APOE
107910 CYTOCHROME P450, FAMILY 19, SUBFAMILY A, POLYPEPTIDE 1; CYP19A1
134370 COMPLEMENT FACTOR H; CFH
138470 COMPLEMENT FACTOR B; CFB
139210 GROWTH-MENTAL DEFICIENCY SYNDROME OF MYHRE
139300 GYNECOMASTIA, HEREDITARY
139320 GNAS COMPLEX LOCUS; GNAS
153700 MACULAR DYSTROPHY, VITELLIFORM; VMD
162200 NEUROFIBROMATOSIS, TYPE I; NF1
171050 ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 1; ABCB1
188000 THROMBOCYTOPENIA 2; THC2
217000 COMPLEMENT COMPONENT 2 DEFICIENCY
218600 BALLER-GEROLD SYNDROME; BGS
220210 DANDY-WALKER-LIKE MALFORMATION WITH ATRIOVENTRICULAR SEPTAL DEFECT
231000 GAUCHER DISEASE, TYPE III
261540 PETERS-PLUS SYNDROME
300377 DYSTROPHIN; DMD
600010 INSULINOMA-ASSOCIATED 1; INSM1
602366 INTEGRIN-LINKED KINASE; ILK
602958 SERUM/GLUCOCORTICOID-REGULATED KINASE; SGK
603075 MACULAR DEGENERATION, AGE-RELATED, 1; ARMD1
603273 TUMOR PROTEIN p73-LIKE; TP73L
603571 VANIN 2; VNN2
603934 COACTIVATOR-ASSOCIATED ARGININE METHYLTRANSFERASE 1; CARM1
604167 CCCTC-BINDING FACTOR; CTCF
604401 ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 6
604817 CARBOHYDRATE SULFOTRANSFERASE 5; CHST5
605112 TROPOMODULIN 3; TMOD3
605566 RETICULON 4 RECEPTOR; RTN4R
605571 PIWI-LIKE 1; PIWIL1
606463 GLUCOSIDASE, BETA, ACID; GBA
606847 TCOF1 GENE; TCOF1
607093 5,10-@METHYLENETETRAHYDROFOLATE REDUCTASE; MTHFR
607340 GAMMA-AMINOBUTYRIC ACID B RECEPTOR 2; GABBR2
607854 BESTROPHIN 1; BEST1
607856 CINGULIN-LIKE 1; CGNL1
608221 MICROTUBULE-ASSOCIATED SERINE/THREONINE KINASE-LIKE; MASTL
608270 THREONINE ASPARTASE 1; TASP1
608795 PHOSPHOLIPASE C, DELTA-3; PLCD3
609803 ANKYRIN AND ARMADILLO REPEATS-CONTAINING PROTEIN; ANKAR
610149 LOC387715 GENE
610308 UDP-GAL:BETA-GlcNAc BETA-1,3-GALACTOSYLTRANSFERASE-LIKE; B3GALTL
610464 G PROTEIN-COUPLED RECEPTOR 156; GPR156
610467 PROTEIN TYROSINE PHOSPHATASE-LIKE (PROLINE INSTEAD OF CATALYTIC ARGININE),

October 5, 2006

New Entries:

300615 BRUNNER SYNDROME
610461 RETICULON 4 RECEPTOR-LIKE 1; RTN4RL1
610462 RETICULON 4 RECEPTOR-LIKE 2; RTN4RL2
610463 NOGOB RECEPTOR
610465 FLJ20920 GENE

Changed Entries:

120920 MEMBRANE COFACTOR PROTEIN; MCP
122920 MOVED TO 304110
134370 COMPLEMENT FACTOR H; CFH
139320 GNAS COMPLEX LOCUS; GNAS
143100 HUNTINGTON DISEASE; HD
147683 INTERLEUKIN 13; IL13
147781 INTERLEUKIN 4 RECEPTOR; IL4R
147811 INTERLEUKIN 1 RECEPTOR, TYPE II; IL1R2
157140 MICROTUBULE-ASSOCIATED PROTEIN TAU; MAPT
158375 MUCIN 7, SALIVARY; MUC7
160900 DYSTROPHIA MYOTONICA 1
161561 INTERLEUKIN 12B; IL12B
189971 E2F TRANSCRIPTION FACTOR 1; E2F1
227400 FACTOR V DEFICIENCY
235400 HEMOLYTIC-UREMIC SYNDROME, ATYPICAL; aHUS
300119 INTERLEUKIN 13 RECEPTOR, ALPHA-1; IL13RA1
305360 MEMBRANE PROTEIN, PALMITOYLATED 1; MPP1
309850 MONOAMINE OXIDASE A; MAOA
309860 MONOAMINE OXIDASE B; MAOB
600018 OPIOID RECEPTOR, MU-1; OPRM1
600515 PURINERGIC RECEPTOR P2Y, G PROTEIN-COUPLED, 12; P2RY12
600807 ASTHMA, SUSCEPTIBILITY TO
602145 PROLIFERATION-ASSOCIATED 2G4, 38-KD; PA2G4
602590 p21/CDC42/RAC1-ACTIVATED KINASE 1; PAK1
602975 MOVED TO 608833
604046 OXIDATIVE STRESS-RESPONSIVE 1; OXSR1
604475 RETICULON 4; RTN4
605232 PROTEIN KINASE, LYSINE-DEFICIENT 1; WNK1
605377 DYSTROPHIA MYOTONICA PROTEIN KINASE; DMPK
605566 RETICULON 4 RECEPTOR; RTN4R
607114 A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 33; ADAM33
607928 WHIRLIN; WHRN
608593 COMPLEMENT FACTOR H-RELATED 5; CFHR5
608833 CHROMOSOME 20 OPEN READING FRAME 41; C20ORF41
609496 MOVED TO 609814
609685 CELL DIVISION CYCLE-ASSOCIATED PROTEIN 7-LIKE; CDCA7L
609814 COMPLEMENT FACTOR H DEFICIENCY

October 4, 2006

New Entries:

610459 PROLINE-RICH PROTEIN 13; PRR13

Changed Entries:

125240 CD55 ANTIGEN; CD55
134371 COMPLEMENT FACTOR H-RELATED 1; CFHR1
143465 ATTENTION DEFICIT-HYPERACTIVITY DISORDER; ADHD
146732 INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 3; IGFBP3
146735 INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 6; IGFBP6
147267 INOSITOL 1,4,5-TRIPHOSPHATE RECEPTOR, TYPE 3; ITPR3
160900 DYSTROPHIA MYOTONICA 1
163500 NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 2; CSNBAD2
164831 LEUKEMIA VIRAL BMI-1 ONCOGENE, MOUSE, HOMOLOG OF; BMI1
180380 RHODOPSIN; RHO
181500 SCHIZOPHRENIA; SCZD
182389 SODIUM CHANNEL, NEURONAL TYPE I, ALPHA SUBUNIT; SCN1A
182390 SODIUM CHANNEL, VOLTAGE-GATED, TYPE II, ALPHA SUBUNIT; SCN2A
182391 SODIUM CHANNEL, VOLTAGE-GATED, TYPE III, ALPHA SUBUNIT; SCN3A
188060 THROMBOSPONDIN I; THBS1
222100 DIABETES MELLITUS, INSULIN-DEPENDENT; IDDM
257270 NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL RECESSIVE
600163 SODIUM CHANNEL, VOLTAGE-GATED, TYPE V, ALPHA SUBUNIT; SCN5A
600235 SODIUM CHANNEL, VOLTAGE-GATED, TYPE I, BETA SUBUNIT; SCN1B
600702 SODIUM CHANNEL, VOLTAGE-GATED, TYPE VIII, ALPHA SUBUNIT; SCN8A
601219 MOVED TO 182390
601298 MOVED TO 102576
603022 E4F TRANSCRIPTION FACTOR 1; E4F1
603415 SODIUM CHANNEL, VOLTAGE-GATED, TYPE IX, ALPHA SUBUNIT; SCN9A
603967 SODIUM CHANNEL, VOLTAGE-GATED, TYPE IV, ALPHA SUBUNIT; SCN4A
604096 GLUTAMATE RECEPTOR, METABOTROPIC, 6; GRM6
604233 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS; GEFS+
604385 SODIUM CHANNEL, VOLTAGE-GATED, TYPE XI, ALPHA SUBUNIT; SCN11A
604427 SODIUM CHANNEL, VOLTAGE-GATED, TYPE X, ALPHA SUBUNIT; SCN10A
604687 PROSTAGLANDIN D2 RECEPTOR; PTGDR
604933 MutY, E. COLI, HOMOLOG OF; MUTYH
605446 RETINITIS PIGMENTOSA GTPase REGULATOR-INTERACTING PROTEIN; RPGRIP1
607745 SEIZURES, BENIGN FAMILIAL NEONATAL-INFANTILE
608214 SODIUM CHANNEL, VOLTAGE-GATED, TYPE III, BETA SUBUNIT; SCN3B
610444 NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 3; CSNBAD3

October 3, 2006

New Entries:

610444 NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 3; CSNBAD3
610445 NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 1; CSNBAD1

Changed Entries:

117141 CENTROMERIC PROTEIN C1; CENPC1
126420 TOPOISOMERASE, DNA, I; TOP1
134820 FIBRINOGEN, A ALPHA POLYPEPTIDE; FGA
134850 FIBRINOGEN, G GAMMA POLYPEPTIDE; FGG
139330 GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-TRANSDUCING ACTIVITY POLYPEPTIDE
141800 HEMOGLOBIN--ALPHA LOCUS 1; HBA1
141850 HEMOGLOBIN--ALPHA LOCUS 2; HBA2
141900 HEMOGLOBIN--BETA LOCUS; HBB
163500 NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 2; CSNBAD2
176914 PROTEIN PHOSPHATASE 1, CATALYTIC SUBUNIT, GAMMA ISOFORM; PPP1CC
176930 COAGULATION FACTOR II; F2
180072 PHOSPHODIESTERASE 6B, cGMP-SPECIFIC, ROD, BETA; PDE6B
180380 RHODOPSIN; RHO
180690 RNA, U2 SMALL NUCLEAR; RNU2
182465 SON DNA-BINDING PROTEIN; SON
203285 MOVED TO 608233
224120 ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE I
227400 FACTOR V DEFICIENCY
230800 GAUCHER DISEASE, TYPE I
268000 RETINITIS PIGMENTOSA; RP
300071 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A; CSNB2A
300600 ALBINISM, OCULAR, TYPE II; OA2
300614 AUDITORY NEUROPATHY, X-LINKED, 1, WITH PERIPHERAL NEUROPATHY
310500 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1; CSNB1
311800 PHOSPHOGLYCERATE KINASE 1; PGK1
400010 DEAD/H BOX 3, Y-LINKED; DBY
600044 THROMBOPOIETIN; THPO
600047 ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 2; ABCA2
601065 ALANYL-tRNA SYNTHETASE; AARS
601445 NADH-UBIQUINONE OXIDOREDUCTASE 1 BETA SUBCOMPLEX, 9; NDUFB9
601772 H2A HISTONE FAMILY, MEMBER X; H2AFX
603401 ADAPTOR-RELATED PROTEIN COMPLEX 3, BETA-1 SUBUNIT; AP3B1
604685 HOMEOBOX A2; HOXA2
605093 LYMPHOCYTE ADAPTOR PROTEIN
605281 DEAD/H BOX 4; DDX4
606027 CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR 1; CPSF1
607005 GEM-ASSOCIATED PROTEIN 5
607058 GAP JUNCTION PROTEIN, ALPHA-9
607465 CODANIN 1; CDAN1
608212 LRG47, MOUSE, HOMOLOG OF
608233 HERMANSKY-PUDLAK SYNDROME 2; HPS2
609812 DIABETES AND PANCREATIC EXOCRINE DYSFUNCTION
610445 NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 1; CSNBAD1

October 2, 2006

New Entries:

300614 AUDITORY NEUROPATHY, X-LINKED, 1, WITH PERIPHERAL NEUROPATHY

Changed Entries:

120150 COLLAGEN, TYPE I, ALPHA-1; COL1A1
122920 MOVED TO 304100
134350 COMPLEMENT FACTOR D; CFD
145420 HYPERTELORISM, TEEBI TYPE
152700 SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
171300 PHEOCHROMOCYTOMA
180849 RUBINSTEIN-TAYBI SYNDROME; RSTS
191160 TUMOR NECROSIS FACTOR; TNF
191540 URATE OXIDASE; UOX
193300 VON HIPPEL-LINDAU SYNDROME; VHL
231100 HEMOCHROMATOSIS, NEONATAL
259420 OSTEOGENESIS IMPERFECTA, PROGRESSIVELY DEFORMING, WITH NORMAL SCLERAE
266200 PYRUVATE KINASE DEFICIENCY OF RED CELLS
300457 NHS GENE; NHS
300530 KAWASAKI DISEASE
300614 AUDITORY NEUROPATHY, X-LINKED, 1, WITH PERIPHERAL NEUROPATHY
302350 NANCE-HORAN SYNDROME; NHS
304110 CRANIOFRONTONASAL SYNDROME; CFNS
561000 RIBOSOMAL RNA, MITOCHONDRIAL, 12S; MTRNR1
600576 GATA-BINDING PROTEIN 4; GATA4
601656 GATA-BINDING PROTEIN 6; GATA6
601769 VITAMIN D RECEPTOR; VDR
601847 CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 2; PFIC2
601973 RETINOIC ACID RECEPTOR RESPONDER 2; RARRES2
602351 CHEMOKINE-LIKE RECEPTOR 1; CMKLR1
603201 ATP-BINDING CASSETTE, SUBFAMILY B, MEMBER 11; ABCB11
604457 NUCLEAR BODY PROTEIN SP110; SP110
604895 T-BOX 21; TBX21
606412 BSND GENE
606463 GLUCOSIDASE, BETA, ACID; GBA
606598 GANGLIOSIDE-INDUCED DIFFERENTIATION-ASSOCIATED PROTEIN 1; GDAP1
607114 A DISINTEGRIN AND METALLOPROTEINASE DOMAIN 33; ADAM33
607948 MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO INFECTION BY
608340 CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE A
609712 PYRUVATE KINASE, LIVER AND RED BLOOD CELL; PKLR

Disclaimer | Write to the Help Desk | Privacy Policy
NCBI | NLM | NIH